Based on the analysis of relevant experiments with T-ALL cells in vivo and in vitro, Fahy et al94 revealed that hypoxia strongly suppresses the growth of CD45/CD7 T-ALL cells, which renders them insensitive to anti-leukemic drugs but retains their proliferative potential after the end of treatment. Here, CD7 is linked to acute lymphoblastic leukemia.